Active10322941Private limited companyLondon

ONCOGEN LIMITED

Owned by Demetris Vassilakos (75–100%)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

01

Summary

Generated from filed data · no estimates

ONCOGEN LIMITED is an active private limited company (company number 10322941) incorporated on 10 August 2016, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 August 2025, showing net assets of −£1,009, with 0 employees on average.

Peer position · net assets

By net assets it sits in the bottom quarter of 603 comparable companies in London (median £440, upper quartile £92k).

02

Key dates

Incorporated
10 August 201610 yrs ago
Next accounts due
30 May 2027in 220 days
Confirmation statement due
24 August 2027in 306 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

03

Activity

SIC 72110
Research and experimental development on biotechnology
Accounts type
Total Exemption Full
Size band
MicroCompanies Act thresholds
04

Financials

2 periods on record · latest ending 30 August 2025
Net assets
−£1,009
vs Aug 2024
Cash at bank
Not reported
Turnover
Not reported
Employees
0
−100%vs Aug 2024
Net assets
−£1,009
Average employees
0
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
30 August 2025−£1,009—————0
30 August 2024£0—————1

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

05

Filing and accounts signals

Facts from the register · no rating
  • Net assets below zeroNet assets £-1,009 at 30 August 2025
  • Incorporated five or more years agoIncorporated 10 August 2016

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

06

Ownership and control

1 active · 1 other
  • Dr Demetris Vassilakos
    Individual · since 10 August 2016
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors
  • persons with significant control statement · since 10 August 2016 · ceased 10 August 2016

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.

07

Timeline

Newest first
  1. Confirmation statement duein 306 days
  2. Next accounts duein 220 days
  3. Accounts period endNet liabilities £1,009 · small accounts
  4. Accounts period endNet assets £0 · small accounts
  5. Incorporated
08

Similar companies in London

Same activity (research and experimental development on biotechnology), closest in incorporation date
09

Reminders for ONCOGEN LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.